0.68%
1.59%
33.83%
50.20%
69.96%
743.40%
1441.38%
AI Spotlight on SNT
Create a Free
Company Description
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland.The company sells medical equipment used in diagnostics and therapy, and nuclear medicine; the development of IT solutions used in radiology; and produces and sells radiopharmaceutical products used in diagnostics for oncology.It also operates a research laboratory for diagnostic imaging systems and a service center for medical equipment.
In addition, the company offers maintenance services for medical equipment, as well as acceptance and specialist tests.Synektik Spólka Akcyjna was founded in 2001 and is based in Warsaw, Poland.
Market Data
| Last Price | 223.5 |
| Change Percentage | 0.68% |
| Open | 221.5 |
| Previous Close | 222 |
| Market Cap ( Millions) | 1906 |
| Volume | 12388 |
| Year High | 241 |
| Year Low | 117 |
| M A 50 | 215.96 |
| M A 200 | 172.75 |
Financial Ratios
| FCF Yield | 1.89% |
| Dividend Yield | 5.05% |
| ROE | 44.98% |
| Debt / Equity | 9.22% |
| Net Debt / EBIDTA | -137.83% |
| Price To Book | 8.54 |
| Price Earnings Ratio | 22.94 |
| Price To FCF | 53.04 |
| Price To sales | 3.42 |
| EV / EBITDA | 14.36 |
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Equipment Diagnostic and Information Technology
Expected Growth : 3.5 %
What the company do ?
Equipment Diagnostic and Information Technology from Synektik Spólka Akcyjna provides real-time monitoring and analytics for industrial equipment, enabling predictive maintenance and optimized performance.
Why we expect these perspectives ?
Synektik Spólka Akcyjna's Equipment Diagnostic and Information Technology segment growth of 3.5% is driven by increasing demand for predictive maintenance, adoption of Industry 4.0 technologies, and rising need for efficient equipment monitoring. Additionally, growing investments in digitalization and automation across industries, such as manufacturing and energy, are also contributing to this growth.
Segment n°2 -> Production of Radiopharmaceuticals
Expected Growth : 4.5 %
What the company do ?
Synektik Spólka Akcyjna produces radiopharmaceuticals using cyclotron and radiochemistry labs, offering a range of products for diagnostic and therapeutic applications.
Why we expect these perspectives ?
Synektik Spólka Akcyjna's 4.5% growth in radiopharmaceutical production is driven by increasing demand for cancer treatments, advancements in nuclear medicine, and strategic partnerships with hospitals and research institutions. Additionally, investments in R&D, expansion of production capacity, and favorable regulatory environments contribute to the company's growth momentum.
Synektik Spólka Akcyjna Products
| Product Range | What is it ? |
|---|---|
| Synektik IoT Platform | A comprehensive IoT platform that enables the connection and management of various devices, sensors, and systems, providing real-time data and insights for informed decision-making. |
| Smart Factory Solutions | A suite of solutions that leverage IoT, AI, and machine learning to optimize manufacturing processes, improve efficiency, and reduce costs. |
| Cybersecurity Services | A range of cybersecurity services, including penetration testing, vulnerability assessment, and incident response, to protect against cyber threats. |
| Data Analytics and AI | Advanced data analytics and AI solutions that provide insights, predictions, and recommendations to drive business growth and improvement. |
| Industrial Automation Solutions | A range of industrial automation solutions, including SCADA systems, PLC programming, and HMI development, to optimize industrial processes. |
| IT Consulting and Integration | Expert IT consulting and integration services to design, implement, and integrate IT systems, ensuring seamless operations and efficiency. |
Synektik Spólka Akcyjna's Porter Forces
Threat Of Substitutes
The threat of substitutes for Synektik Spólka Akcyjna is moderate due to the presence of alternative products and services in the market.
Bargaining Power Of Customers
The bargaining power of customers is high due to the availability of alternative products and services, and the ability of customers to switch to competitors.
Bargaining Power Of Suppliers
The bargaining power of suppliers is low due to the company's strong relationships with suppliers and the availability of alternative suppliers.
Threat Of New Entrants
The threat of new entrants is moderate due to the presence of barriers to entry, such as high capital requirements and regulatory hurdles.
Intensity Of Rivalry
The intensity of rivalry is high due to the presence of several competitors in the market, and the need to differentiate products and services to gain a competitive advantage.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 12.33% |
| Debt Cost | 9.81% |
| Equity Weight | 87.67% |
| Equity Cost | 9.81% |
| WACC | 9.81% |
| Leverage | 14.06% |
Synektik Spólka Akcyjna : Quality Control
Synektik Spólka Akcyjna passed 8 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| CHEMM.CO | ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in … |
| EUZ.DE | Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and … |
| GBT.PA | Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and … |
| ELN.MI | EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields … |
| DRW3.DE | Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Synektik
A-Score
1-Year Total Return ->
🥈
EL.En
A-Score
1-Year Total Return ->
🥉
Drägerwerk
A-Score
1-Year Total Return ->
4
ChemoMetec
A-Score
1-Year Total Return ->
5
Eckert & Ziegler
A-Score
1-Year Total Return ->
6
